Marta Laganà,Alfredo Berruti,Salvatore Grisanti et al.
Marta Laganà et al.
Purpose of review: Oligometastatic adrenocortical carcinoma (ACC) represents a distinct clinical subset of metastatic disease characterized by a limited tumor burden and potentially indolent biology. This review summarize...
Lilla Horvath,Kristiina Boettiger,Zsolt Megyesfalvi et al.
Lilla Horvath et al.
Purpose of review: Small cell lung cancer (SCLC), particularly its transdifferentiated form, is highly aggressive and has a poor prognosis. The diagnosis of SCLC transdifferentiation is challenging, as repeat biopsies are...
Martin Svaton
Martin Svaton
Purpose of review: Lung cancer in pregnancy is relatively rare, however, with increasing gestational age, its incidence is likely to increase. Many of the summary recommendations were developed before the advent of target...
The evolving landscape of bispecific antibodies in the treatment of lung cancer [0.03%]
双特异抗体在肺癌治疗中的应用及其发展前景
Xuanhong Jin,Chang Chang,Fei Zhou
Xuanhong Jin
Purpose of review: Lung cancer, the leading cause of cancer mortality, faces persistent challenges like resistance to targeted therapy and immunotherapy. This review comprehensively outlines the evolving role of bispecifi...
Systemic therapy of nonsmall cell lung cancer: breakthroughs during the last five decades [0.03%]
非小细胞肺癌的系统治疗：过去五十年间取得突破性进展
Robert Pirker,Caicun Zhou
Robert Pirker
Purpose of review: The purpose of this review is to summarize the breakthroughs in the systemic treatment of patients with nonsmall cell lung cancer (NSCLC) during the last five decades. ...
Antibody-drug conjugates in lung cancer: current landscape and future perspectives [0.03%]
抗体偶联药物在肺癌中的研究现状与未来展望
Xinru Chen,Caicun Zhou
Xinru Chen
Purpose of review: Antibody-drug conjugates (ADCs) have emerged as a significant therapeutic class in lung cancer, integrating the target specificity of monoclonal antibodies with the cytotoxic potency of chemotherapeutic...
Yongsheng Wang,Liyun Miao,Caicun Zhou
Yongsheng Wang
Purpose of review: This review focuses on the current role of artificial intelligence (AI) in lung cancer screening, diagnosis and therapy. We also highlight its strengths in improving the accuracy and efficiency of these...
State of the art and future directions in the treatment of metastatic adenoid cystic carcinoma [0.03%]
腺样囊性癌转移治疗的现状和未来方向
Rachel Galot,Jean-Pascal H Machiels
Rachel Galot
Purpose of review: Metastatic adenoid cystic carcinoma (ACC) remains a therapeutic challenge with no approved systemic standard of care. This review highlights recent advances in ACC biology and emerging therapeutic strat...
Insulin resistance and metabolic dysfunction in thyroid nodules and differentiated thyroid cancer [0.03%]
甲状腺结节和分化型甲状腺癌的胰岛素抵抗和代谢紊乱
Stefano Iuliano,Maria Mirabelli,Stefania Giuliano et al.
Stefano Iuliano et al.
Purpose of review: The global rise in obesity, metabolic syndrome (MetS), insulin resistance (IR), and type 2 diabetes mellitus (T2DM) is reshaping the epidemiology of thyroid disorders, particularly thyroid nodular disea...
Beyond the usual - Atypical imaging presentation in lung cancer and implications for TNM-staging [0.03%]
不典型肺癌的影像学表现及其对TNM分期的影响
Daria Kifjak,Rebecca Mura,Svitlana Pochepnia et al.
Daria Kifjak et al.
Purpose of review: This review illustrates the spectrum of atypical computed tomography (CT) appearances of lung cancer and provides practical guidance for accurate diagnosis and staging. ...